Profile Previews

Get a glimpse into our company and investor data—powered by the PitchBook Platform

IO Biotech

IO Biotech
2014 FOUNDED
PRIVATE STATUS
Series A LATEST DEAL TYPE
$12M LATEST DEAL AMOUNT
3 INVESTORS
Description

Developer of vaccine designed to offer cancer treatments. The company's vaccine develops immunotherapy for cancer by targeting a mechanism used by tumour cells to evade immune responses.

Ownership Status
Privately Held (backing)
Financing Status
Venture Capital-Backed
Primary Industry
Biotechnology
Primary Office
  • Ole Maaløes Vej 3
  • 2200 Copenhagen
  • Denmark

+45 21 00 00 00
Request full access to PitchBook

You’re viewing a free company profile from the PitchBook Platform. To explore IO Biotech’s full profile, request a free trial.

IO Biotech Valuation and Funding

Deal Type Date Amount Raised to Date Post-Val Status Stage
2. Early Stage VC (Series A) 05-Jan-2016 $12M 0000 Completed Generating Revenue
1. Early Stage VC Completed Startup
To view this company’s complete deal history including valuation and funding, request access »

IO Biotech Competitors (26)

Company Name Financing Status Location Employees Total Raised Last Financing Date/Type Last Financing Amount
Aura Biosciences Venture Capital-Backed Cambridge, MA 00 00000 00000000000 00000
0000 000000 Formerly VC-backed Santa Monica, CA 000 00000 000000&0 00000
00000000000 000000 Formerly VC-backed Abingdon, United Kingdom 000 00000 000000 - 000 00000
000000000 Venture Capital-Backed Rockville, MD 000.00 0000000000 0 000.00
000000000000 Venture Capital-Backed Houston, TX 000.00 00000000000 000.00
To view this company’s complete list of competitors, request access »

IO Biotech Investors (3)

Investor Name Investor Type Holding Investor Since Participating Rounds Board
Seat
Contact
Info
Lundbeckfonden Limited Partner Minority 000 0000 000000 0
Novo Holdings Corporate Venture Capital Minority 000 0000 000000 0
Sunstone Life Science Ventures Venture Capital Minority 000 0000 000000 0

IO Biotech Executive Team (5)

Name Title Board
Seat
Contact
Info
Mads Andersen Ph.D Chief Scientific Officer & Co-Founder & Board Member
Inge Svane Ph.D Co-Founder & Clinical Advisor
Per Straten Co-Founder
Mai-Britt Zocca Ph.D Chief Executive Officer & Co-Founder
Bo Anders Ljungqvist Co-Founder & CMC

IO Biotech Board Members (5)

Name Representing Role Since Contact
Info
Christian Elling Ph.D Lundbeckfonden Board Member 000 0000
Peter Hirth Ph.D Self Board Member 000 0000
Stephan Christgau Ph.D Novo Holdings Board Member 000 0000

2 Former Board Members

You’re viewing 3 of 5 board members. Get the full list »